Related Experiment Videos
Oligodendroglioma: the Rotterdam-Dijkzigt experience
J M Kros1, H Pieterman, C G van Eden
1Department of Pathology/Neuropathology, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Neurosurgery
|June 1, 1994
Summary
Oligodendroglioma grade and tumor site significantly impact patient survival. Frontal lobe tumors and lower grades correlate with better outcomes, while radiation therapy showed no survival benefit in this study.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pathology
Background:
- Oligodendroglioma is a primary brain tumor with variable clinical courses.
- Prognostic factors influencing survival require precise definition for optimal patient management.
Purpose of the Study:
- To investigate the impact of various clinicopathological factors on the survival of patients with oligodendroglioma.
- To determine the interdependencies between tumor grade, site, patient age, and treatment modalities on clinical outcomes.
Main Methods:
- Retrospective analysis of 82 oligodendroglioma cases.
- Evaluation of tumor grade, size, site (frontal vs. nonfrontal), patient age, surgical extent, and radiation therapy.
- Statistical analysis to assess the influence of these factors on survival rates.
Main Results:
- Tumor grade and tumor site were significant prognostic factors for survival.
- Frontal lobe location was associated with a favorable prognosis, independent of tumor grade.
- Younger patient age showed a slight positive correlation with survival, linked to tumor location and grade.
- Tumor volume and radiation therapy did not demonstrate a significant correlation with survival outcomes.
- Decompression surgery trended towards longer survival but did not reach statistical significance.
Conclusions:
- Tumor grade and frontal location are key determinants of oligodendroglioma patient survival.
- Age influences prognosis indirectly through its association with tumor characteristics.
- Current evidence does not support a survival benefit from radiation therapy in this cohort.